Treatment with novel oral anticoagulants in a real-world cohort of patients undergoing cardiac rhythm device implantations

Safety of Continuous Anticoagulation With Dabigatran During Implantation of Cardiac Rhythm Devices

(2013) Christopher P. Rowley et al.   AMERICAN JOURNAL OF CARDIOLOGY

Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation

(2013) David H. Birnie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin

(2012) Jeff S. Healey et al.   CIRCULATION

Meta-Analysis of Bleeding Complications Associated With Cardiac Rhythm Device Implantation

(2012) Michael L. Bernard et al.   Circulation-Arrhythmia and Electrophysiology

Wound Complications Following Rivaroxaban Administration

(2012) Simon S Jameson et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation

(2012) Jack Ansell et al.   THROMBOSIS AND HAEMOSTASIS

The 11th World Survey of Cardiac Pacing and Implantable Cardioverter-Defibrillators: Calendar Year 2009-A World Society of Arrhythmia's Project

(2011) HARRY G. MOND et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial

(2009) J. M. Tolosana et al.   EUROPEAN HEART JOURNAL